TrialClinical lung cancer2021

A Dose-finding Study Followed by a Phase II Randomized, Placebo-controlled Trial of Chemoradiotherapy With or Without Veliparib in Stage III Non-small-cell Lung Cancer: SWOG 1206 (8811).

Athanassios Argiris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.